ClinicalTrials.gov Oversteps Corporate Confidentiality Protections – Merck
Executive Summary
The trial information required for the ClinicalTrials.gov database undermines corporate confidentiality protections, Merck maintained in comments to HHS' Committee on Regulatory Reform
You may also be interested in...
ClinicalTrials.Gov Compliance Varies By FDA Review Division, Report Finds
Industry participation in HHS' ClinicalTrials.gov database fluctuated widely by FDA review division, according to an agency report on the progress of implementing the federally-mandated database
ClinicalTrials.Gov Compliance Varies By FDA Review Division, Report Finds
Industry participation in HHS' ClinicalTrials.gov database fluctuated widely by FDA review division, according to an agency report on the progress of implementing the federally-mandated database
ClinicalTrials.gov Postings By Industry Increase, But Still Appear Incomplete
The ClinicalTrials.gov database includes over 650 open protocols sponsored by the pharmaceutical industry as of June 17